Sertraline Hydrochloride
- Product NDC
- 71335-0328
- 11-digit product format
- 713350328
- Labeler code
- 71335
- Product ID
- 71335-0328_0b420eee-e7ab-473f-82ee-254286e4a8aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sertraline Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077397
- Marketing category
- ANDA
- Marketing start
- 2016-07-21
- Substance
- SERTRALINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Sertraline Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SERTRALINE HYDROCHLORIDE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | UTI8907Y6X |
| Rxcui | 312940 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-0328-1 | 2024-05-17 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-2 | 2024-05-17 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-3 | 2024-05-17 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-4 | 2024-05-17 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-5 | 2024-05-17 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-6 | 2024-05-17 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
| 71335-0328-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-6928-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SERTRALINE TABLETS safely and effectively. See full prescribing information for SERTRALINE TABLETS. SERTRALINE tablets, for oral use Initial U.S. Approval: 1991 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-0328-1 | Sertraline Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | | 8 |
| 71335-0328-2 | Sertraline Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | | 8 |
| 71335-0328-3 | Sertraline Hydrochloride | 90 in 1 BOTTLE | TABLET | 90 | | 8 |
| 71335-0328-4 | Sertraline Hydrochloride | 180 in 1 BOTTLE | TABLET | 180 | | 8 |
| 71335-0328-5 | Sertraline Hydrochloride | 28 in 1 BOTTLE | TABLET | 28 | | 8 |
| 71335-0328-6 | Sertraline Hydrochloride | 120 in 1 BOTTLE | TABLET | 120 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-0328 | SERTRALINE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 8 | Current NDC, Legacy NDC, 6 package rows | 20240518_22c4b114-5f70-4c64-aa7f-b4169729b847.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0328-1 | 71335032801 | 30 TABLET in 1 BOTTLE (71335-0328-1) | 30 tablet | 2018-02-13 | 0000-00-00 | No | No | Current |
| 71335-0328-2 | 71335032802 | 60 TABLET in 1 BOTTLE (71335-0328-2) | 60 tablet | 2018-02-20 | 0000-00-00 | No | No | Current |
| 71335-0328-3 | 71335032803 | 90 TABLET in 1 BOTTLE (71335-0328-3) | 90 tablet | 2018-02-26 | 0000-00-00 | No | No | Current |
| 71335-0328-4 | 71335032804 | 180 TABLET in 1 BOTTLE (71335-0328-4) | 180 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0328-5 | 71335032805 | 28 TABLET in 1 BOTTLE (71335-0328-5) | 28 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |
| 71335-0328-6 | 71335032806 | 120 TABLET in 1 BOTTLE (71335-0328-6) | 120 tablet | 2021-12-27 | 0000-00-00 | No | No | Current |